Garin, Etienne http://orcid.org/0000-0003-1416-2863
Guiu, Boris
Edeline, Julien
Rolland, Yan
Palard, Xavier
Article History
Received: 3 November 2021
Accepted: 26 June 2022
First Online: 18 August 2022
Declarations
:
: Etienne Garin is consultant for Boston Scientific and reports receiving a grant, personal fees, and non-financial support from Boston Scientific. Boris Guiu is consultant for Boston Scientific declares that he has no conflict of interest. Julien Edeline reports receiving a grant from Boston Scientific during the conduct of the study; personal fees from Boston Scientific, Bayer, Roche, Eisai, Merck Sharpe & Dohme, AstraZeneca and Ipsen; grants and personal fees from Bristol Myers Squibb; and non-financial support from Amgen, outside the submitted work. Yan Rolland reports receiving a grant from Boston Scientific.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, informed consent is not required.
: For this type of study, consent for publication is not required.